(Last updated : 2022-05-24 14:13:37)
  岡脇 誠
   Department     ,
   Position   Assistant Professor
■ BooK
1. 2011/03   Adoptive Immunotherapy of Cancer Using Autologous Lymphocytes, Cancer Growth and Progression 
■ Journal
1. 2021/11 Concordance of acquired mutations between metastatic lesions and liquid biopsy in metastatic colorectal cancer  Link
2. 2021/05 Clinical and epigenetic features of colorectal cancer patients with somatic POLE proofreading mutations  Link
3. 2020/08/24 Adoptive immunotherapy for gastric cancer using zoledronate‑activated killer cells: A prospective observational study 
4. 2020/07 Metronidazole-Induced Encephalopathy during the Treatment of Advanced Esophageal Squamous Cell
Carcinoma 
5. 2019/11 Intervention by a palliative care team for patients undergoing allogeneic hematopoietic stem cell transplantation 
Display all(16)
■ Presentation
1. 2022/02/17 Fluctuating PD-1 ratio in blood may predict clinical outcome of upper gastrointestinal cancer patients under ICI therapy  
2. 2021/11/12 Validation and development of the diagnostic technology for Lynch syndrome exclusion by a DNA
chip detecting MLH1 methylation and BRAF V600E mutations in colorectal cancer  
3. 2019/07/05 Poor prognosis of hypermutant colorectal cancer with KRAS mutations: A retrospective analysis of 1,052 Japanese colorectal cancer patients without treatment of immuno-checkpoint inhibitors   Link
4. 2019/04/01 Comparing effects of small molecular weight compounds on proliferation and chemotaxis of pancreatic cancer cells   Link
5. 2018/11/24 Efficacy of Ramucirumab in combination with second-line or salvage-line FOLFIRI in patients with metastatic colorectal cancer.  
Display all(24)